United States · Bill · HR
H.R. 4869 (106th)
Prescription Drug Fairness Act
Introduced
18 July 2000
Last action
—
Status
Referred to the House Committee on the Judiciary.
Sponsors
—
Subjects
Discovery layer
Source updated
20 August 2025
Summary
Prescription Drug Fairness Act - Amends the Clayton Act to deem: (1) the sale of a prescription drug by a manufacturer outside the United States to be the sale of such drug within the United States for purposes of provisions prohibiting price discrimination; and (2) discrimination in price between wholesalers within the United States and wholesalers outside the United States substantially to injure, destroy, or prevent competition with any person who either grants or knowingly receives the benefit of such discrimination, or with customers of either of them.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 18 July 2000
Introduced in House (PDF)
Introduced in House · EN · 18 July 2000
Introduced in House
summary · EN · 18 July 2000
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/106th-congress/house-bill/4869
- Open data entity: https://api.congress.gov/v3/bill/106/hr/4869